logo

For the Inventor, By the Inventor

Barcelona, Spain

Miguel Molina Vila

This inventor holds 1 USPTO granted patent. Top assignee: Progenika Biopharma S.a.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Miguel Molina Vila. Retrieved from https://idiyas.com/inventor/miguel-molina-vila

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal1 out of 16 
 
Progenika Biopharma S.a.
 patents

Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents
1. 8124331 - In vitro method to detect bladder transitional cell carcinoma (2012-02-28),

Title: Miguel Molina Vila: Innovator in Cancer Detection

Introduction

Miguel Molina Vila is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of medical diagnostics, particularly in cancer detection. His innovative work focuses on developing methods that can improve the diagnosis and treatment of bladder cancer.

Latest Patents

Miguel holds a patent for an in vitro method to detect bladder transitional cell carcinoma. This invention aims to determine the stage or severity of bladder cancer in individuals. It also monitors the effects of therapy administered to patients suffering from this type of cancer. The method is designed to screen for, identify, develop, and evaluate the efficacy of therapeutic compounds against bladder cancer. Additionally, it targets agents that inhibit the expression and/or activity of the FGFR3 protein.

Career Highlights

Miguel Molina Vila is associated with Progenika Biopharma S.A., a company dedicated to advancing biopharmaceutical solutions. His work at Progenika has been instrumental in pushing the boundaries of cancer diagnostics and treatment options.

Collaborations

Miguel collaborates with talented professionals in his field, including Simon Santa Cruz and Corina Junquera Sánchez-Vallejo. Their combined expertise contributes to the innovative projects at Progenika Biopharma.

Conclusion

Miguel Molina Vila's contributions to cancer detection through his patented methods highlight his role as an important inventor in the medical field. His work continues to pave the way for advancements in cancer diagnostics and treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…